Fund: PARWHCE
BNP Paribas Funds Health Care Innovators [Classic, C] | |
LU0823416762 | |
17-05-2013 | |
Equity | |
Equity Sectors - Health Care | |
BNP PARIBAS FUNDS | |
BNP Paribas Asset Management USA, Inc. | |
James Haynie | |
EUR | |
100 | |
3% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | 1.50% | 7.26% | 11.14% | 22.95% | 17.44% | 7.08% | 10.78% | 9.42% | 9.56% | N/A | |
Priemerná výkonnosť (36 meraní) | 0.68% | 7.52% | 10.33% | 10.06% | 7.68% | ||||||
Volatilita od priemernej výkonnosti | 6.31% | 13.68% | 6.08% | 3.35% | 3.30% |
Long | Short | Net | |
---|---|---|---|
Stock | 98.81% | 98.81% | |
Bond | |||
Other | |||
Cash | 1.19% | 1.19% |
Aktíva | 12,115 mil. |
Počet akcíí | 47 |
Počet dlhopisov | 0 |
Priebež. popl. | 1.98 |
z toho Mng. popl. | 1.50 |
Výk. prémia | |
Trans. popl. | 0.08 |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 33.23% |
Large | 25.65% |
Medium | 17.39% |
Small | 14.55% |
Micro | 6.34% |
P/E | 21.61% |
P/BV | 3.80% |
Healthcare | 98.81% |
Derivatives | 1.19 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
United States | 70.91% |
Canada | 0.59% |
Latin America | |
United Kingdom | 8.99% |
Eurozone | 7.82% |
Europe - ex Euro | 7.78% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | 2.72% |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 98.81% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Eli Lilly and Co | Healthcare | 8.39% | AstraZeneca PLC | Healthcare | 7.16% |
UnitedHealth Group Inc | Healthcare | 6.93% | Sanofi SA | Healthcare | 5.33% |
Boston Scientific Corp | Healthcare | 4.7% | Thermo Fisher Scientific Inc | Healthcare | 4.39% |
Regeneron Pharmaceuticals Inc | Healthcare | 4.05% | Neurocrine Biosciences Inc | Healthcare | 3.26% |
Hologic Inc | Healthcare | 3.11% | Centene Corp | Healthcare | 2.83% |